GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (XMAD:GRF) » Definitions » Net Margin %

Grifols (XMAD:GRF) Net Margin % : 2.88% (As of Sep. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Grifols Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Grifols's Net Income for the three months ended in Sep. 2024 was €52 Mil. Grifols's Revenue for the three months ended in Sep. 2024 was €1,793 Mil. Therefore, Grifols's net margin for the quarter that ended in Sep. 2024 was 2.88%.

The historical rank and industry rank for Grifols's Net Margin % or its related term are showing as below:

XMAD:GRF' s Net Margin % Range Over the Past 10 Years
Min: 0.9   Med: 12.78   Max: 15.35
Current: 2.6


XMAD:GRF's Net Margin % is ranked worse than
53.37% of 995 companies
in the Drug Manufacturers industry
Industry Median: 3.96 vs XMAD:GRF: 2.60

Grifols Net Margin % Historical Data

The historical data trend for Grifols's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Net Margin % Chart

Grifols Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.26 11.58 3.83 3.43 0.90

Grifols Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.29 3.73 4.16 0.82 2.88

Competitive Comparison of Grifols's Net Margin %

For the Drug Manufacturers - General subindustry, Grifols's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grifols's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's Net Margin % distribution charts can be found below:

* The bar in red indicates where Grifols's Net Margin % falls into.



Grifols Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Grifols's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=59.315/6591.977
=0.90 %

Grifols's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=51.691/1792.956
=2.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grifols  (XMAD:GRF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Grifols Net Margin % Related Terms

Thank you for viewing the detailed overview of Grifols's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Grifols Business Description

Address
Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.